A new multinational clinical trial marks a significant step in developing transformative gene therapies for rare inherited disorders.
A new multinational clinical trial marks a significant step in developing transformative gene therapies for rare inherited disorders.
Ionis Pharmaceuticals is driving progress in antisense technology, demonstrating meaningful advances in genetic disease treatment
Moderna pushes the boundaries of mRNA therapy into rare genetic diseases, aiming for transformative treatments.
Manufacturing breakthroughs are set to transform cell therapy production, paving the way for faster trials and wider patient …
Australia’s National Genomic Registry is connecting patients, clinicians, and researchers to transform rare disease care in real time.
Australian-led clinical trials are advancing the future of diabetes care with oral insulin innovations.
New device approval and robust oncology funding highlight ongoing biopharma momentum in cancer therapies.
Despite economic caution, pharma and biotech leaders invest boldly to reshape pipelines and accelerate innovation.
Next-generation gene editing powers new hope for hard-to-treat solid tumors in early human trials.
Already a subscriber? Log in